{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T11:55:47Z","timestamp":1765540547391,"version":"3.48.0"},"reference-count":10,"publisher":"Walter de Gruyter GmbH","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7,26]]},"DOI":"10.1515\/jbcpp-2017-0166","type":"journal-article","created":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T01:24:22Z","timestamp":1531445062000},"page":"309-311","source":"Crossref","is-referenced-by-count":0,"title":["Blister-packed levothyroxine sodium or bottle-packed levothyroxine sodium"],"prefix":"10.1515","volume":"29","author":[{"given":"Deepak","family":"Gupta","sequence":"first","affiliation":[{"name":"Clinical Assistant Professor, Anesthesiology , Wayne State University\/Detroit Medical Center, Box No 162, 3990 John R , Detroit, MI 48201 , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarwan","family":"Kumar","sequence":"additional","affiliation":[{"name":"Internal Medicine, Wayne State University , Detroit, Michigan , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berhane","family":"Seyoum","sequence":"additional","affiliation":[{"name":"Internal Medicine, Division of Endocrinology, Wayne State University , Detroit, Michigan , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2018,6,27]]},"reference":[{"key":"2025121209133011279_j_jbcpp-2017-0166_ref_001_w2aab2b8c65b1b7b1ab2b2b1Aa","doi-asserted-by":"crossref","unstructured":"Hennessey JV. Generic vs. name brand L-thyroxine products: interchangeable or still not? J Clin Endocrinol Metab 2013;98:511\u20134.","DOI":"10.1210\/jc.2012-4310"},{"key":"2025121209133011279_j_jbcpp-2017-0166_ref_002_w2aab2b8c65b1b7b1ab2b2b2Aa","doi-asserted-by":"crossref","unstructured":"Mudie DM, Murray K, Hoad CL, Pritchard SE, Garnett MC, Amidon GL, et al. Quantification of gastrointestinal liquid volumes and distribution following a 240 mL dose of water in the fasted state. Mol Pharm 2014;11:3039\u201347.","DOI":"10.1021\/mp500210c"},{"key":"2025121209133011279_j_jbcpp-2017-0166_ref_003_w2aab2b8c65b1b7b1ab2b2b3Aa","unstructured":"Jane-Gale P, Yergey AL, Duncan MW. Quantifying small molecules by mass spectrometry. LCGC North America 2015;33:34\u201341."},{"key":"2025121209133011279_j_jbcpp-2017-0166_ref_004_w2aab2b8c65b1b7b1ab2b2b4Aa","doi-asserted-by":"crossref","unstructured":"Urban PL. Clarifying misconceptions about mass and concentration sensitivity. J Chem Educ 2016;93:984\u20137.","DOI":"10.1021\/acs.jchemed.5b00986"},{"key":"2025121209133011279_j_jbcpp-2017-0166_ref_005_w2aab2b8c65b1b7b1ab2b2b5Aa","doi-asserted-by":"crossref","unstructured":"Won CM. Kinetics of degradation of levothyroxine in aqueous solution and in solid state. Pharm Res 1992;9:131\u20137.","DOI":"10.1023\/A:1018952415732"},{"key":"2025121209133011279_j_jbcpp-2017-0166_ref_006_w2aab2b8c65b1b7b1ab2b2b6Aa","doi-asserted-by":"crossref","unstructured":"Hamad ML, Engen W, Morris KR. Impact of hydration state and molecular oxygen on the chemical stability of levothyroxine sodium. Pharm Dev Technol 2015;20:314\u20139.","DOI":"10.3109\/10837450.2013.862635"},{"key":"2025121209133011279_j_jbcpp-2017-0166_ref_007_w2aab2b8c65b1b7b1ab2b2b7Aa","unstructured":"U.S. Food & Drug Administration. FDA acts to ensure thyroid drugs don\u2019t lose potency before expiration date. Available at: https:\/\/www.fda.gov\/drugs\/drugsafety\/postmarketdrugsafetyinformationforpatientsandproviders\/ucm161259.htm. Accessed: 28 Sep 2017."},{"key":"2025121209133011279_j_jbcpp-2017-0166_ref_008_w2aab2b8c65b1b7b1ab2b2b8Aa","doi-asserted-by":"crossref","unstructured":"McAninch EA, Bianco AC. The history and future of treatment of hypothyroidism. Ann Intern Med 2016;164:50\u20136.","DOI":"10.7326\/M15-1799"},{"key":"2025121209133011279_j_jbcpp-2017-0166_ref_009_w2aab2b8c65b1b7b1ab2b2b9Aa","doi-asserted-by":"crossref","unstructured":"Prasad V, Mailankody S. Research and development spending to bring a single cancer drug to market and revenues after approval. JAMA Intern Med 2017;177:1569\u201375.","DOI":"10.1001\/jamainternmed.2017.3601"},{"key":"2025121209133011279_j_jbcpp-2017-0166_ref_010_w2aab2b8c65b1b7b1ab2b2c10Aa","unstructured":"Prescription Drug Products; Levothyroxine Sodium. Notice. Fed Regist 1997;62:43535\u20138. https:\/\/www.gpo.gov\/fdsys\/pkg\/FR-1997-08-14\/pdf\/97-21575.pdf."}],"container-title":["Journal of Basic and Clinical Physiology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/jbcpp.2018.29.issue-4\/jbcpp-2017-0166\/jbcpp-2017-0166.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2017-0166\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2017-0166\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T11:51:25Z","timestamp":1765540285000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2017-0166\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,27]]},"references-count":10,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,10]]},"published-print":{"date-parts":[[2018,7,26]]}},"alternative-id":["10.1515\/jbcpp-2017-0166"],"URL":"https:\/\/doi.org\/10.1515\/jbcpp-2017-0166","relation":{},"ISSN":["2191-0286","0792-6855"],"issn-type":[{"type":"electronic","value":"2191-0286"},{"type":"print","value":"0792-6855"}],"subject":[],"published":{"date-parts":[[2018,6,27]]}}}